ADC Therapeutics SA announced that, in the event of a change of control, the acquirer will continue to pay royalties to the healthcare royalty company until the originally agreed cap amount is reached.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Global News You Need to Know Before the U.S. Stock Market Opens on Monday
ProCap Financial discloses bitcoin holdings of 5,007 BTC and repurchases 148,241 common shares
Trending news
MoreInvestment firm Oppenheimer recently initiated coverage on Public Policy Holding Co., giving the stock an "Outperform" rating and setting a target price of $16.
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Optimumfunding, a lending platform under Home Bancorp, has announced the expansion of its loan product line to include bridge loans and Federal Housing Administration (FHA) loans.
Crypto prices
More
